Nautilus Biotechnology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $242.7M
Liabilities Breakdown FY2024
Total Liabilities: $34.0M
Asset Breakdown
Total Assets: $242.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $27.6M | 11.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.1M | 1.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $211.0M | 86.9% |
Liabilities Breakdown
Total Liabilities: $34.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $987.0K | 2.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $33.0M | 97.1% |